CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 2, 2021

Conditions
Retinitis PigmentosaDry Age-related Macular Degeneration
Interventions
BIOLOGICAL

Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP)

"A subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) will be performed only in one eye, the other eye will be considered as a control group.~A complete morpho-functional ophthalmological evaluation will be performed in all patient at each control."

Trial Locations (1)

00168

Alfonso Savastano, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER